Email Updates

You are here

AVAC's Blog: P-Values

  • Manasseh Phiri — dear friend and partner, a doctor, writer and radio journalist, activist, advocate, mentor and farmer — has passed away.

    April 22, 2019
    Mitchell Warren
  • Now up on our Px Pulse page, and available on your favorite podcast platform, is our latest episode of Px Pulse: "The Science of Choice — The future of HIV prevention research". This episode features unmissable conversations about some of the challenges associated with today’s HIV prevention options, and analysis about what should be in the research pipeline of the future.

    April 8, 2019
  • A redesigned is now at your fingertips! The search engine is more powerful, the site navigation is cleaner and simpler, and you will continue to find the rich selection of resources that inform PrEP introduction around the world. Since 2006, has been home to information on PrEP research, data, cost, access, implementation and advocacy around the world.

    April 4, 2019
  • The three-week PEPFAR Regional Planning Meetings (RPM) wrapped up—and week two included a fresh group of countries, some familiar patterns and some new ideas. One of the most important takeaways to consider is the need for ongoing attention to this work. PEPFAR engagement is a 365-day effort, and the wins in the room are sometimes fragile.
    March 22, 2019
    Emily Bass
  • What does the “HVTN” in HVTN 702 stand for? And why do some trials, such as the mosaic vaccine trial HVTN705/HPX2008, carry two interchangeable tags? Also, what’s a mosaic vaccine, and why was it developed? Where are the studies happening, and when can we expect results?

    Research literacy for HIV prevention advocates involves clarifying these types of questions. Current and accurate knowledge about clinical trials allows an advocate to engage confidently in the clinical trial ecosystem, which includes researchers, communities, ethics boards, and even funders. A recent gathering was a reminder of how effective it can be to conduct these sessions in an informal, low-tech setting, to invest in their knowledge of HIV prevention science.

    March 13, 2019
    Daisy Ouya
    Chilufya Hampongo
  • Every year, programs under the US Government’s President’s Emergency Plan for AIDS Relief (PEPFAR) make plans, set targets and define approaches for more than 50 countries around the world. This year, the process began on March 4, and will continue for three weeks in Johannesburg, with countries arriving in groups for the Regional Planning Meetings (RPM).
    March 8, 2019
    Emily Bass
  • The annual Conference on Retroviruses and Opportunistic Infections (CROI) is taking place from March 4-7 in Seattle. Read on for a short guide to help follow along, whether from near or from afar. We also highlight anticipated data.

    March 1, 2019
  • and have several new resources and updates. We've rounded up a few select resources. Take a look!

    February 27, 2019
    General, Microbicides, PrEP
  • Incorporating stakeholder engagement early and deeply in the development of a clinical trial for HIV prevention research is for us a clarion call. Including a diverse cross-section of expertise and perspectives at the outset, especially of those who may rely on these strategies to prevent HIV, helps research stay on track to eventually deliver options people will trust and use.

    February 21, 2019
    Jeanne Baron
    Manju Chatani-Gada
  • AVAC wants to hear from you! We launched our podcast, Px Pulse, in late 2017 and since then we have produced 15 episodes bringing you interviews, first-person reflections and rich discussions covering issues facing HIV prevention research and advocacy. Now it’s time for us to take stock and learn more about what you want from Px Pulse and how to deliver it.

    February 19, 2019